Vsee Health (VSEE) Stock Price

Vsee Health Inc generates revenue through its subsidiaries VSee and iDoc. VSee offers a no-code SaaS platform enabling clinicians and enterprises to build telehealth workflows without programming, providing patient engagement, clinician staffing, remote physical exams, and AI solutions for telesitters and telenursing. iDoc operates as an acute care organization delivering 24/7 neurointensive care, cardiac surgery ICU, and stroke ICU services, offering teleneurointensivists for neuro-critical care. The company's products target healthcare providers seeking efficient telehealth integration and specialized critical care services. VSee's clients include hospitals and healthcare enterprises needing rapid telehealth system deployment, while iDoc serves hospitals requiring specialized neuro-critical care teams. The telehealth platform caters to clinics and hospitals aiming to enhance patient engagement and remote monitoring capabilities. iDoc's services are specifically utilized by facilities managing neuro-ICU, CSICU, and stroke ICU cases, providing expert staffing for critical neurological conditions. The company monetizes through subscription-based SaaS models for VSee's telehealth platform and direct service fees for iDoc's acute care services. VSee's no-code solution appeals to healthcare organizations looking to avoid development costs, while iDoc's specialized staffing model addresses gaps in critical care staffing for neurological emergencies. Both segments target healthcare institutions requiring scalable, specialized digital health solutions.